SMV
Sofinnova Management VIII Portfolio holdings
AUM
$183M
This Quarter Return
-0.66%
1 Year Return
+2.31%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$178M
AUM Growth
–
Cap. Flow
+$178M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Aclaris Therapeutics
ACRS
|
$62.1M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$45.2M |
| 3 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$35.2M |
| 4 |
Natera
NTRA
|
$18.2M |
| 5 |
CYTO
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
|
$6.22M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 74.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Aclaris Therapeutics
ACRS
$209M
| $62.1M | 34.97% | +2,289,480 | New | +$62.1M |
|
|
ONCE
2
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $45.2M | 25.41% | +904,986 | New | +$45.2M |
|
|
ARAV
3
DELISTED
Aravive, Inc. Common Stock
ARAV
| $35.2M | 19.8% | +2,361,978 | New | +$35.2M |
|
|
4
Natera
NTRA
$23.1B
| $18.2M | 10.22% | +1,550,280 | New | +$18.2M |
|
|
CYTO
5
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $6.23M | 3.5% | +5,818,175 | New | +$6.22M |
|
6
Synlogic
SYBX
$17M
| $5.36M | 3.01% | +2,974,812 | New | +$5.36M |
|
7
Ocugen
OCGN
$319M
| $3.47M | 1.95% | +2,077,040 | New | +$3.47M |
|
|
INNL
8
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $1.45M | 0.82% | +2,103,173 | New | +$1.45M |
|
|
SPHS
9
DELISTED
Sophiris Bio, Inc.
SPHS
| $560K | 0.32% | +200,000 | New | +$560K |
|